These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 31599424)
1. MicroRNA-1271 inhibits the progression of papillary thyroid carcinoma by targeting IRS1 and inactivating AKT pathway. Chen Y; Hao SA; Jiang Y; Gao B; Tian WG; Zhang S; Guo LJ; Wang LL; Luo DL Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7989-7999. PubMed ID: 31599424 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-31 inhibits papillary thyroid carcinoma cell biological progression by directly targeting SOX11 and regulating epithelial-to-mesenchymal transition, ERK and Akt signaling pathways. Wang Y; Liu BG; Zhou CX Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5863-5873. PubMed ID: 31298337 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-26a suppresses the malignant biological behaviors of papillary thyroid carcinoma by targeting ROCK1 and regulating PI3K/AKT signaling pathway. Wu YC; Li SY; Jia YF Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8940-8949. PubMed ID: 31696481 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-486 inhibits cell proliferation, invasion and migration via down-regulating the TENM1 expressions and affecting ERK and Akt signaling pathways and epithelial-to-mesenchymal transition in papillary thyroid carcinoma. Sun YH; Liu ZF; Yang BB; Yu B Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8429-8439. PubMed ID: 31646573 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-203 restrains epithelial-mesenchymal transition, invasion and migration of papillary thyroid cancer by downregulating AKT3. You A; Fu L; Li Y; Li X; You B Cell Cycle; 2020 May; 19(10):1105-1121. PubMed ID: 32308106 [TBL] [Abstract][Full Text] [Related]
6. miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3β/Snail signaling by targeting ARFGEF1. Han J; Zhang M; Nie C; Jia J; Wang F; Yu J; Bi W; Liu B; Sheng R; He G; Kong L; Zheng L; Pang R; Ding Z; Chen L; Guan Q; Pan S; Meng X; Xu J; Liu L; Zhang J Cell Death Dis; 2019 Feb; 10(3):195. PubMed ID: 30814512 [TBL] [Abstract][Full Text] [Related]
7. miRNA-21 promotes cell proliferation and invasion via VHL/PI3K/AKT in papillary thyroid carcinoma. Zang C; Sun J; Liu W; Chu C; Jiang L; Ge R Hum Cell; 2019 Oct; 32(4):428-436. PubMed ID: 31161410 [TBL] [Abstract][Full Text] [Related]
8. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor. Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA‑766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway. Zhao J; Li Z; Chen Y; Zhang S; Guo L; Gao B; Jiang Y; Tian W; Hao S; Zhang X Int J Oncol; 2019 Jan; 54(1):315-325. PubMed ID: 30387841 [TBL] [Abstract][Full Text] [Related]
10. MiR-192-5p inhibits proliferation, migration, and invasion in papillary thyroid carcinoma cells by regulation of SH3RF3. Fu S; Ma C; Tang X; Ma X; Jing G; Zhao N; Ran J Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34486645 [TBL] [Abstract][Full Text] [Related]
11. Exosomal circular RNA hsa_circ_007293 promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through regulation of the microRNA-653-5p/paired box 6 axis. Lin Q; Qi Q; Hou S; Chen Z; Jiang N; Zhang L; Lin C Bioengineered; 2021 Dec; 12(2):10136-10149. PubMed ID: 34866540 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression. Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471 [TBL] [Abstract][Full Text] [Related]
13. microRNA-599 promotes apoptosis and represses proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells via downregulation of Hey2-depentent Notch signaling pathway. Wang DP; Tang XZ; Liang QK; Zeng XJ; Yang JB; Xu J J Cell Physiol; 2020 Mar; 235(3):2492-2505. PubMed ID: 31565805 [TBL] [Abstract][Full Text] [Related]
14. MiR-630 inhibits papillary thyroid carcinoma cell growth, metastasis, and epithelial-mesenchymal transition by suppressing JAK2/STAT3 signaling pathway. Pan XM; He XY; Yang YL; Jia WJ; Yang ZQ; Yan D; Ma JX Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2453-2460. PubMed ID: 30964171 [TBL] [Abstract][Full Text] [Related]
15. Circ_0079558 promotes papillary thyroid cancer progression by binding to miR-26b-5p to activate MET/AKT signaling. Zheng H; Fu Q; Ma K; Shi S; Fu Y Endocr J; 2021 Nov; 68(11):1247-1266. PubMed ID: 34565758 [TBL] [Abstract][Full Text] [Related]
16. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2. Xue KC; Hu DD; Zhao L; Li N; Shen HY Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3794-3800. PubMed ID: 28975989 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-520a-3p suppresses epithelial-mesenchymal transition, invasion, and migration of papillary thyroid carcinoma cells via the JAK1-mediated JAK/STAT signaling pathway. Bi CL; Zhang YQ; Li B; Guo M; Fu YL J Cell Physiol; 2019 Apr; 234(4):4054-4067. PubMed ID: 30206929 [TBL] [Abstract][Full Text] [Related]
18. MiR-96-5p promotes the proliferation, invasion and metastasis of papillary thyroid carcinoma through down-regulating CCDC67. Liu ZM; Wu ZY; Li WH; Wang LQ; Wan JN; Zhong Y Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3421-3430. PubMed ID: 31081096 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis. Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764 [TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor. Feng K; Liu Y; Xu LJ; Zhao LF; Jia CW; Xu MY Biomed Pharmacother; 2018 Aug; 104():686-698. PubMed ID: 29803929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]